Beyond the lungs: understanding cardiopulmonary risk in COPD

Chronic obstructive pulmonary disease (COPD) is widely recognised as a respiratory condition, but growing evidence shows it is also a significant cardiovascular health concern. This healthcare professional resource from Lung Foundation Australia explores the important connection between COPD and cardiovascular disease (CVD), highlighting why cardiopulmonary risk should be a routine consideration in COPD management. 

People living with COPD face an increased risk of serious cardiovascular events, including heart attack, heart failure, atrial fibrillation and stroke. Importantly, this risk is not limited to patients with known cardiovascular disease. COPD-related systemic inflammation, hypoxia and physiological stress can contribute to endothelial dysfunction, plaque instability and cardiac strain, particularly during and after exacerbations. 

The resource explains how COPD exacerbations act as critical turning points for future health outcomes. Research shows the risk of cardiovascular complications rises sharply following an exacerbation and can remain elevated for more than 12 months. Even a first exacerbation may signal worsening disease progression and an increased likelihood of future respiratory and cardiac events. 

Designed for Australian general practitioners and primary care clinicians, this guide outlines practical strategies to identify patients at higher cardiopulmonary risk, assess cardiovascular health, and implement preventive care. Key recommendations include optimising inhaler therapy, promoting smoking cessation, ensuring appropriate vaccination, supporting pulmonary rehabilitation, and maintaining a low threshold for cardiovascular assessment following exacerbations. 

The resource also highlights the importance of post-exacerbation reviews as opportunities to strengthen COPD management and reduce long-term cardiopulmonary risk. By taking a proactive and integrated approach, healthcare professionals can help prevent exacerbations, improve quality of life, reduce hospitalisations, and lower the risk of cardiovascular complications. 

Whether you manage patients with newly diagnosed COPD or advanced disease, this evidence-based resource provides valuable insights into the relationship between lung and heart health and reinforces a key clinical message: stabilising COPD helps protect both the lungs and the heart.